Have Your Eggs and Your Statin and Your PCSK9 inhibitor too
The cholesterolfighting market is back with a vengeance; plenty of complications in store Date Mon 20150309 All day Article Sort Author workspaceSpacesStorebc...
View ArticleSynthetic Biologics to Report Year End 2014 Financial Results
ROCKVILLE Md. March 9 2015 PRNewswire &160;Synthetic Biologics Inc. NYSE MKT SYN a developer of pathogenspecific therapies for serious infections and diseases with a focus on protecting the...
View ArticleStatin Adverse Effects Much More Common than Appreciated States Journal of...
TUCSON Ariz. March 9 2015 PRNewswireUSNewswire &160;Family physician Duane Graveline M.D. a former astronaut used to prescribe statin drugs enthusiastically to lower cholesterol. Then he took them...
View ArticleCardioBreak Modern Bloodletting a New Statin Strategy
MedPage Today Recent developments of interest in cardiovascular medicine.
View ArticleDoes the LDL Receptor Play a Role in the Risk of Developing Type 2 Diabetes
Over the last 5 years major randomized clinical trials and metaanalyses of these trials have indicated that statin therapy which inhibits 3hydroxy3methylglutarylCoA reductase HMGCR is associated with a...
View ArticleStatin Intolerance Reconciling Clinical Trials and Clinical Experience
This Viewpoint discusses the benefits of statins and factors related to statin intolerance.
View ArticleCan statins help improve prostate cancer survival
HealthDayCholesterollowering statin drugs may slow down prostate cancer in men who are also taking medication to reduce their levels of male hormones according to new research.
View ArticleSynthetic Biologics' SYN004 Data for Protection of Microbiome Selected for...
ROCKVILLE Md. March 11 2015 PRNewswire &160;Synthetic Biologics Inc. NYSE MKT SYN a developer of pathogenspecific therapies for serious infections and diseases with a focus on protecting the...
View ArticleGenetic high cholesterol 'may help protect against type 2 diabetes'
"High cholesterol LOWERS the risk of diabetes" is the Daily Mail's rather misleading headline going on to say that "New study reveals why taking statins may be...
View ArticleGenetic Disorder FH Informs How Statins Boost Diabetes Risk
A significantly reduced risk for type 2 diabetes in familial hypercholesterolemia patients may offer insights into the increased diabetes risk seen with statin therapy. Medscape Medical News
View ArticleGenetic Risk Score Could Show Who Benefits Most From Statins
The genetic risk score comprising 27 SNPs previously linked with coronary disease in genetic studies could help riskstratify patients who would benefit the most from statin therapy. Heartwire from...
View ArticleStatin guidelines miss middleage patients and overtarget seniors
Duke University Medical Center The newest guidelines for the use of cholesterollowering statins in people at risk of heart disease may be too generic excluding middleaged adults who could benefit from...
View ArticleEsperion Therapeutics to Present at Bank of America Merrill Lynch Smid Cap...
ANN ARBOR MIMarketwired March 12 2015 Esperion Therapeutics Inc. NASDAQ ESPR an emerging pharmaceutical company focused on developing and commercializing firstinclass oral lowdensity lipoprotein...
View ArticleStatin guidelines miss middleage patients overtarget seniors
The newest guidelines for the use of cholesterollowering statins in people at risk of heart disease may be too generic excluding middleaged adults who could benefit from the drugs and overprescribing...
View ArticleFast Thoughts Esperion ESPR Corcept CORT Raptor RPRP Anacor ANAC Macrogenics...
I have gotten some requests for information and this allows me to try a much briefer format.Esperion Therapeutics ESPRESPR has been making a nice run these past few days. Has it shot up past its prime...
View ArticleNew Detailed Data From Phase 3 Study Show Amgen's Repatha Evolocumab In...
THOUSAND OAKS Calif. March 14 2015 PRNewswire Amgen NASDAQAMGN today announced new detailed data from the Phase 3 YUKAWA2 study evaluating Repatha&8482; evolocumab a novel investigational...
View ArticleFirst Look Esperion Study 008 Full Results
On Saturday March 14 2015 Esperion investigators presented the full results from Study 008 at the American College of Cardiology 64th Annual Scientific Session. This is being accomplished through a...
View ArticleEsperion Study 008 Briefing II Implications
On Saturday March 14 2015 Esperion investigators presented the full results from Study 008 at the American College of Cardiology 64th Annual Scientific Session. We summarized these results in our...
View ArticleRegeneron and Sanofi Announce 18Month Results of ODYSSEY LONG TERM Trial with...
TARRYTOWN N.Y. and PARIS March 15 2015 PRNewswire Regeneron Pharmaceuticals Inc. NASDAQ REGN and Sanofi today announced that 18month 78week results of a Phase 3 trial of Praluent&8482; alirocumab...
View Article